Data / Form D filings / Ocuphire Pharma, Inc.
Ocuphire Pharma, Inc.: Form D filings
Ocuphire Pharma, Inc., a biotechnology company in Farmington Hills, MI, filed 4 Form D notices with the SEC between 2018 and 2020. The latest, on February 3, 2020, reports $2.1 million sold of a $2.1 million offering to 4 investors.
Find out what Ocuphire Pharma, Inc. does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 37000 Grand River Ave, Suite 120, Farmington Hills, MI, 48335
- Phone
- (248) 681-9815
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Year incorporated
- 2018
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1738266
The full lists. Form D filings in Michigan: 506 rows, $25.30, or the new rows each week for $19 a month. Form D filings in Biotechnology: 1,568 rows, $78.40, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, street, city, state, ZIP and 4 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Feb 3, 2020 | New notice | $2,126,253 | $2,126,253 | $0 | 4 | Jan 21, 2020 | sec.gov |
| Feb 6, 2019 | Amendment | $10,000,000 | $1,774,460 | $8,225,540 | 21 | May 25, 2018 | sec.gov |
| Jun 5, 2018 | New notice | $5,000,000 | $734,460 | $4,265,540 | 8 | May 25, 2018 | sec.gov |
| Apr 24, 2018 | New notice | $17,000 | $17,000 | $0 | 72 | Apr 10, 2018 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Alan Meyer | Director | |
| Cam Gallagher | Director | |
| Mina Sooch | Executive Officer, Director | |
| Bernhard Hoffmann | Executive Officer | |
| Sean Ainsworth | Director | |
| James Manuso | Director |
Other biotechnology companies in Michigan that filed recently
- Dvant Pharma, Inc. $1.2 million · Oct 13, 2026
- iReprogram, Inc offering · Aug 13, 2026
Every Form D from the week of Feb 3, 2020 · All recent filings in Michigan · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what Ocuphire Pharma, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.